Immunizations

Pfizer signs are seen out front of the Pfizer Research & Development Laboratories Wednesday, July 22, 2020, in Groton, Conn. Pfizer on Tuesday, July 28, reported a 32% plunge in second-quarter profit, as the global coronavirus pandemic limited marketing of and new prescriptions for its medicines. Still, the biggest U.S. drugmaker posted a solid profit and nudged up parts of its 2020 financial forecast. (AP Photo/Stew Milne)
October 27, 2020 - 4:49 am
Drugmaker Pfizer saw its third-quarter profit plunge 71%, mainly due to an $8.1 billion gain a year earlier from selling its consumer health care business to a GlaxoSmithKline joint venture, but managed to top Wall Street expectations. Meanwhile, the New York-based company on Tuesday said...
Read More
President Donald Trump speaks at a campaign rally at Manchester-Boston Regional Airport, Sunday, Oct. 25, 2020, in Londonderry, N.H. (AP Photo/Alex Brandon)
October 25, 2020 - 7:33 pm
LONDONDERRY, N.H. (AP) — The coronavirus has reached the upper echelons of the White House again, with an outbreak among aides to Vice President Mike Pence just over a week from Election Day. A top White House official declared: “We’re not going to control the pandemic.” Officials on Sunday also...
Read More
Vice President Mike Pence speaks to supporters Saturday Oct. 24, 2020 in Tallahassee, Fla. Battleground Florida was again a central focus of the presidential campaign Saturday as President Donald Trump, Vice President Mike Pence and former President Barack Obama all had high-profile events in the state. (AP Photo/Steve Cannon)
October 25, 2020 - 2:33 pm
WASHINGTON (AP) — The Latest on the presidential campaign (all times local): 5:35 p.m. Vice President Mike Pence will be campaigning in Minnesota after all on Monday, after a text message from the Trump-Pence campaign indicated the two would be together in Allentown, Pennsylvania. The vice...
Read More
October 23, 2020 - 3:58 pm
SAO PAULO (AP) — Brazil’s health regulator has authorized the import from China of a potential vaccine against the coronavirus, just days after President Jair Bolsonaro insisted he wouldn't allow doses to be shipped from the Asian nation. The health regulator, Anvisa, said in a statement Friday...
Read More
FILE - In this Wednesday, June 24, 2020 file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. On Friday, Oct. 23, 2020, AstraZeneca Inc. announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S. (Siphiwe Sibeko/Pool via AP)
October 23, 2020 - 3:30 pm
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates. Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study...
Read More
Members of the festival organizing team at the Kali Bari Hindu temple pray via live transmission on the first day of Durga Puja celebrations in New Delhi, India, Thursday, Oct. 22, 2020. Most of the festival festivities are being scaled down following the health officials warning about the potential for the coronavirus to spread during the religious festival season, which is marked by huge gatherings in temples and shopping districts. (AP Photo/Manish Swarup)
October 23, 2020 - 4:27 am
NEW DELHI (AP) — A promise of free COVID-19 vaccination has become an issue in key state elections in India. Finance Minister Nirmala Sitharaman made the promise when releasing the ruling Hindu nationalist party’s manifesto for elections that begin in Bihar state next week. Every Bihar resident...
Read More
FILE - In this July 27, 2020, file photo, Nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. The U.S. Food and Drug Administration will hold a meeting to discuss the process of approving COVID-19 vaccines. (AP Photo/Hans Pennink, File)
October 22, 2020 - 5:26 pm
WASHINGTON (AP) — Scientific advisers told U.S. regulators Thursday they’re concerned that allowing emergency use of a COVID-19 vaccine could damage confidence in the shots and make it harder to ever find out how well they really work. The Food and Drug Administration may have to decide by year's...
Read More
In this photo provided by Cincinnati Children’s Hospital Medical Center, clinical research coordinator Tammy Lewis-McCauley administers an injection to Katelyn Evans, a trial participant, as part of the hospital’s clinical trial of Pfizer's COVID-19 vaccine at Cincinnati Children’s Hospital Medical Center on Wednesday, Oct. 14, 2020. (Cincinnati Children’s Hospital Medical Center via AP)
October 21, 2020 - 1:02 pm
The global hunt for a COVID-19 vaccine for kids is only just beginning — a lagging start that has some U.S. pediatricians worried they may not know if any shots work for young children in time for the next school year. Older adults may be most vulnerable to the coronavirus, but ending the pandemic...
Read More
Brazil's President Jair Bolsonaro listens during a presentation at the Planalto Presidential Palace in Brasilia, Brazil, Monday, Oct. 19, 2020. The Brazilian government announced the results of clinical tests with use of the drug Nitazoxanide for COVID-19 treatment. (AP Photo/Eraldo Peres)
October 21, 2020 - 11:32 am
SAO PAULO (AP) — Brazil's President Jair Bolsonaro rejected on Wednesday the announced purchase of 46 million doses of a potential vaccine against COVID-19 being developed by a Chinese company and tested in the state governed by his political rival, prompting concern he was allowing politics to...
Read More
FILE - In this Wednesday, Aug. 5, 2020 file photo, senior Clinical Research Nurse Ajithkumar Sukumaran prepares the COVID 19 vaccine to administer to a volunteer, at a clinic in London. The British government on Thursday, Sept. 24, 2020 says it may take part in a study that tries to deliberately infect volunteers who have been given an experimental vaccine against the coronavirus in an effort to more quickly determine if the vaccine works. The approach, called a challenge study, is risky but proponents think it may produce results faster than typical studies, which wait to see if volunteers who have been given an experimental treatment or a dummy version get sick. (AP Photo/Kirsty Wigglesworth, File)
October 20, 2020 - 3:28 am
LONDON (AP) — U.K. researchers are preparing to begin a controversial experiment that will infect healthy volunteers with coronavirus to study the disease in hopes of speeding up the development of a vaccine. The approach, called a challenge study, is risky but proponents say it may produce results...
Read More

Pages